key: cord-0936425-q052ruao
authors: Lee, Ya-Ling; Chu, Dachen; Chou, Sin-Yi; Hu, Hsiao-Yun; Huang, Sheng-Jean; Yen, Yung-Feng
title: Dental care and infection-control procedures during the COVID-19 pandemic: the experience in Taipei City Hospital, Taiwan
date: 2020-05-29
journal: J Dent Sci
DOI: 10.1016/j.jds.2020.05.011
sha: 03d7c82a304f3fae6d52f638adb39bd76e6bc185
doc_id: 936425
cord_uid: q052ruao

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has now widely spread globally. The main transmission routes of SARS-CoV-2 comprise human-to-human droplet infection, including inhalation and contact infection of patient’s saliva, blood and other body fluids through oral mucosa, nasal mucosa, and the eyes, and orofecal transmission. Dental treatment necessitates close-proximity, face-to-face practices and can generate droplets or aerosols containing water, saliva, blood, microorganisms, and other debris during the procedure. Therefore, dental professionals are at a high risk of SARS-CoV-2 infection. To prevent nosocomial SARS-CoV-2 spread during dental procedures, Taipei City Hospital established a dental patient triage and workflow algorithm for the provision of dental services during the COVID-19 pandemic. Given the highly contagious nature of SARS-CoV-2, it is imperative to institute an appropriate standard procedural policy for patient management and recommendation of dental treatment at hospitals during the COVID-19 pandemic.

Coronavirus disease 2019 (COVID-19) induces a severe, atypical, infectious 2 pneumonia and has spread rapidly from Wuhan City, China. 1 Between December 2019 and 3

May 5, 2020, there have been more than 3.6 million confirmed cases of COVID-19 and over 4 257,239 deaths. Worldwide, more than 187 countries are battling the COVID-19 outbreak and 5 are affected by this highly infectious disease. On January 30, 2020, the World Health 6

Organization (WHO) declared this global pneumonia outbreak as the 6th Public Health 7

Emergency of International Concern of the past decade and on March 11, 2020, the outbreak 8 status was upgraded from epidemic to pandemic by the WHO. 9

To face this rapidly emerging infectious disease, we reviewed the literature about the 10 newly emerged virus and provided a standard operating procedure, dental health facilities to 11 combat and prevent further global spread of the pandemic. 12

The global impact and comparison of three major diseases caused 1 by coronaviruses 2 Seven coronaviruses are known to cause human disease and in particular three highly 3 pathogenic coronaviruses strains caused severe acute respiratory syndrome (SARS), Middle 4

East Respiratory Syndrome (MERS) and COVID-19, generate more serious outcomes. 2 (SARS-CoV-2) has an average incubation period of 5.2 days; however, some studies had 16

shown longer incubation periods of up to 14 days. The R0 was reported to be 1.4-2.5 by the 17 WHO on January 18, 2020, and other studies have estimated the R0 to be between 1.5 and 18

3.5. 3 The WHO reported that the overall CFR of COVID-19, as of March 3, was 3.4%, and it 1 increased to 7.02% on May 5, 2020. This value varies considerably among different countries 2 and regions depending on the level of the outbreak, rate of infection, and availability of 3 medical facilities. Until May 5, 2020, the CFR of COVID-19 was 1.4% (6deaths/438 4 confirmed cases) in Taiwan. develop. The common symptoms include fever, coughing, fatigue, sputum, dyspnea, myalgia, 10 anorexia, sore throat, stuffy nose, wheezing, headache, and diarrhea et al. 1, 2 During symptom 11 onset, higher viral loads were detected in patients, especially in the nasal cavity than in the 12 pharynx. 6 13

patients with mild flu-like symptoms or those who may be even asymptomatic. 7 According to 15 a study published in Nature, 8 viral loads in the SARS-CoV-2 patient can be detected as early 16 as the onset of atypical or very mild symptoms. The viral loads in the initial 5 days reached 17 peak concentrations that were a 1000-fold higher than that of the SARS-CoV during the same 18 period. The transmission rate of SARS-CoV-2 is enhanced because of transmission from 1 pre-symptomatic and asymptomatic carriers. 9 2

Evidence from studies have shown that SARS-CoV-2 can 3 survive in aerosols for up to 3 hours and is capable of surviving for up to 4 and 24 hours on 4 copper and cardboard, respectively. Furthermore, the virus can survive on plastic and 5 stainless-steel surfaces for approximately 48 and 72 hours, respectively. 5 SARS-CoV-2 is 6 stable on contaminated surfaces and in aerosols, 10 the risk of nosocomial transmission is high. 7

Healthcare providers face a high occupational risk of SARS-CoV-2 infection and 8 standardized procedural policies for patient management on hospital arrival are imperative for 9 risk mitigation during the COVID-19 pandemic. 10 11 Dental patient triage and workflow during the COVID-19 1 pandemic in the hospital 2 COVID-19 poses a higher risk for dental practitioners, as many routine dental 3 interventions involve aerosol-generating procedures. Dentists come into contact with the 4 saliva and blood of patients and also inhale airborne particles and aerosols produced during 5 dental procedures as well as patient exhalation. The Taiwan CDC care guidelines and 6 standards for dental care during the pandemic recommend the use of Level 3 PPE, including 7 medical standard N95 face masks, disposable waterproof gowns, goggles, and face shields for 8 dental personnel. 9

At present, there are no large-scale community infections in Taiwan. Approximately 10 86% of confirmed cases were imported carriers. In patients with suspected COVID-19 11 infection, emergent dental conditions can be treated while ensuring complete personal 12 protection of dental practitioners. 13

The Taipei City Hospital is a 4,700-bed regional healthcare organization with 7 branches for dental treatment to contain nosocomial COVID-19 transmission at the beginning of the 1 COVID-19 pandemic in February 2020 (Fig 1) . 2

When a patient arrives at the screening door of the hospital, strict rules are to be 3 enforced and complied with. Everyone is required to wear a face mask, the body temperature 4 is recorded, (≧37.5°C marked as fever), and history of travel, occupation, contact, and cluster 5 (TOCC) is ascertained. Patients with fever and TOCC are directly escorted to the emergency 6 department (ED) through a special passage. We regard the temperature higher than 37.5°C as 7 fever, the guideline is as the same as of that in Japan and Korea compared to 38°C in Hong 8

Kong and 100°F (=37.78°C) in the guideline of ADA. The relative TOCC records are also 9 collected in the above countries. A visitor with the travel history of COVID-19 outbreaking 10 area during the last 3 weeks is not allowed to enter hospital access of the Asan Medical 11

Center in Seoul, Korea. 12

If a dental patient has no fever or TOCC concerns, they proceed to the Department of 13

Dentistry and undergo a second screening. The patient's outbound record is checked via the 14 Taiwan National Health Insurance Cloud System before treatment performed. The dental 15 treatment is undertaken with a focus on minimizing aerosol-generating practices by 16 decreasing the usage of the rotary and high-speed handheld devices, together with 17 high-powered suction, rubber dam application, and hand curettage instead of ultrasonic 18

cleaning. Scheduling of patient appointments during this period is limited and the next patient 19 enters the clinic only after the previous patient has left the room and all room 1 decontamination procedures have been completed. Each dental treatment space is separated 2 by high wall coverage to limit the possibility of cross-contamination by aerosols in the 3 environment and the clinic isolation room has a single dental chair only. 4

In the ED, a physician initially evaluates the patient with fever or positive TOCC and 5 decides whether the patient needs to be tested for COVID-19 diagnosis. All suspected cases 6 of COVID-19 would be isolated and monitored. If a patient has persistent dental issues, the 7 ED doctor will request a dental consultation. A dentist would undertake an initial patient 8 evaluation via telemedicine or telephonic consultation. For a patient who is quarantined at the 9 hospital because of COVID-19, dental conditions are initially evaluated by a physician 10 followed by referral for a telemedicine dental consultation, if required. 11

Individuals under home self-quarantine and quarantined in a designated quarantine site 12 due to overseas travel history or contact tracing to confirmed cases can call the epidemic 13 prevention call center helpline 1922 for instructions and assistance for urgent dental concerns. 14 As mentioned above, an initial dental evaluation via telemedicine or telephone consultation is 15 undertaken to assess the patient's dental problem. We had an example of successfully solving 16 the oral problems of an elderly person who was isolated in a central quarantine site and 17 complained of chewing pain while wearing his removable prosthesis via telephone 18 consultation. We taught the patient how to relieve the pain and suggested the caregiver of 1 quarantine site to arrange soft-diet for him. 2 Based on the telemedicine or telephonic consultation, all non-emergent dental concerns 3 will be delayed until COVID-19 symptoms have improved and the quarantine ends. In 4 patients with a true dental emergency, dental care can be provided in an isolated or a 5 negative-pressure treatment room by personnel using Level 3 PPE. 6

The SARS-CoV-2 can survive on various surfaces from a few hours to days. Therefore, 7 treatment room sanitation and disinfection with the appropriate disinfection guidelines is 8 needed to decrease contact transmission. 9

This standard triage and workflow protocol is well performed in Taipei City Hospital 10 and should be suitable to other community and regional hospitals. The dental practitioners of 11 the private dental clinics have to access the patients' condition including body temperature 12 and TOCC before any dental treatment performed under the complete Level 3 PPE protection. 13

To postpone non-emergency dental treatments of the suspected patients and referred the 14 high-risk patients to hospital for emergency dental treatments are recommended. 15 16 Conclusion 1 Dental procedures necessitate close-proximity, face-to-face practices and involves the 2 use of rotary instruments, high-speed handheld tools, air-water syringes and sharp surgical 3 instrument. These procedures create visible aerosol sprays containing droplets with an 4 admixture of water, saliva, blood, and other debris that are potentially contaminated with 5 SARS-CoV-2, which increase the infection risk among dental personnel. 6

There are concerns associated with asymptomatic carrier transmission so a strict 7 well-designed triage and workflow protocol is needed for dental professionals to screen 8 against high-risk patient infection transmission and reduce the potential risk of nosocomial 9 COVID-19 transmission developed from the dental department. 

A novel coronavirus from patients with pneumonia in

A pneumonia outbreak associated with a new 4 coronavirus of probable bat origin

The reproductive number of

COVID-19 is higher compared to SARS coronavirus

MERS-CoV: a global challenge

Air, surface environmental, and personal protective 9 equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 10 from a symptomatic patient

SARS-CoV-2 viral load in upper respiratory specimens 12 of infected patients

Presumed asymptomatic carrier transmission of COVID-19

Virological assessment of hospitalized 16 patients with COVID-2019

Potential presymptomatic transmission of SARS-CoV-2

Aerosol and surface stability of

SARS-CoV-2 as compared with SARS-CoV-1

Manuscript title:

All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, including participation in the concept, design, analysis, writing, or revision of the manuscript. Furthermore, each author certifies that this material or similar material has not been and will not be submitted to or published in any other publication.Indicate the specific contributions made by each author (list the authors' initials followed by their surnames, e.g., Y.L. Chang). The name of each author must appear at least once in each of the three categories below.

Conception and design of study: , , , ;acquisition of data: , , , ;analysis and/or interpretation of data: , , , .

Drafting the manuscript: , , , ;revising the manuscript critically for important intellectual content: , , , .

Approval of the version of the manuscript to be published (the names of all authors must be listed):

All persons who have made substantial contributions to the work reported in the manuscript (e.g., technical help, writing and editing assistance, general support), but who do not meet the criteria for authorship, are named in the Acknowledgments and have given us their written permission to be named. If we have not included an Acknowledgments in our manuscript, then that indicates that we have not received substantial contributions from non-authors. 

A conflict of interest occurs when an individual's objectivity is potentially compromised by a desire for financial gain, prominence, professional advancement or a successful outcome. JDS Editors strive to ensure that what is published in the Journal is as balanced, objective and evidence-based as possible. Since it can be difficult to distinguish between an actual conflict of interest and a perceived conflict of interest, the Journal requires authors to disclose all and any potential conflicts of interest.

The authors whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patentlicensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.Author names:

The authors whose names are listed immediately below report the following details of affiliation or involvement in an organization or entity with a financial or non-financial interest in the subject matter or materials discussed in this manuscript. Please specify the nature of the conflict on a separate sheet of paper if the space below is inadequate.Author names: